3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 2
1
Status
Terminated
2
Recruiting
2
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Xanthomatosis, Cerebrotendinous
1
Influenza, Human
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
98
pembrolizumab
87
Gemcitabine
81
Carboplatin
63
fludarabine
62
Nivolumab
57
Cisplatin
54
Paclitaxel
51
Radiotherapy
50
Docetaxel
50
Rituximab
46
Dexamethasone
42
Lenalidomide
41
Ipilimumab
38
Azacitidine
35
Etoposide
34
Cytarabine
34
Temozolomide
32
Bevacizumab
32
Radiation
29
venetoclax
28
Bortezomib
27
Magnetic Resonance Spectroscopy
26
Irinotecan
26
atezolizumab
25
Pemetrexed
25
Oxaliplatin
24
Capecitabine
24
fludarabine phosphate
23
Filgrastim
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Terminated
×
Diphtheria-Tetanus Vaccine
×
Clear all
NCT03334305
2026-04-23
ACTION
University of Florida
Phase 1
Terminated
18 enrolled
11 charts
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled